Boothbay Fund Management’s Elevance Health ELV Stock Holding History

Boothbay Fund Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.32M	Buy	6,000 +4,426	+281%	+$1.64M	0.03%	661
2026 Q1	$461K	Buy	+1,574	New	+$517K	0.01%	1398
2025 Q4	–	Sell	-3,370	Closed	-$1.09M	–	2070
2025 Q3	$1.09M	Buy	+3,370	New	+$1.05M	0.02%	805
2024 Q4	–	Sell	-1,314	Closed	-$683K	–	1610
2024 Q3	$683K	Buy	1,314 +943	+254%	+$504K	0.02%	881
2024 Q2	$201K	Buy	+371	New	+$196K	﹤0.01%	1290
2024 Q1	–	Sell	-869	Closed	-$410K	–	1668
2023 Q4	$410K	Sell	869 -637	-42%	-$295K	0.01%	1065
2023 Q3	$656K	Buy	1,506 +780	+107%	+$354K	0.02%	926
2023 Q2	$323K	Buy	+726	New	+$335K	0.01%	1267
2023 Q1	–	Sell	-10,397	Closed	-$5.33M	–	2238
2022 Q4	$5.33M	Buy	10,397 +9,771	+1,561%	+$4.96M	0.12%	215
2022 Q3	$284K	Sell	626 -441	-41%	-$211K	0.01%	1572
2022 Q2	$515K	Buy	+1,067	New	+$528K	0.01%	1158
2020 Q1	–	Sell	-2,214	Closed	-$669K	–	901
2019 Q4	$669K	Buy	+2,214	New	+$609K	0.06%	413
2018 Q2	–	Sell	-1,300	Closed	-$286K	–	780
2018 Q1	$286K	Buy	+1,300	New	+$305K	0.03%	491
2016 Q2	–	Sell	-3,214	Closed	-$446K	–	563
2016 Q1	$446K	Buy	3,214 +1,668	+108%	+$223K	0.11%	264
2015 Q4	$216K	Buy	+1,546	New	+$213K	0.1%	380

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boothbay Fund Management's ELV Position: Q2 2026 in Review

Boothbay Fund Management increased its Elevance Health (ELV) stake by 281% in Q2 2026, buying an estimated $1.64M and bringing the position to 6,000 shares worth $2.32M. The position accounts for 0.03% of the portfolio, ranked #661.

Boothbay Fund Management first reported a position in ELV in Q4 2015 and has held it in 15 quarters since. The position peaked at $5.33M in Q4 2022. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Boothbay Fund Management held 6,000 shares of Elevance Health worth $2.32M as of Q2 2026.
Boothbay Fund Management bought 4,426 Elevance Health shares in Q2 2026, an estimated $1.64M.
Elevance Health made up 0.03% of Boothbay Fund Management's portfolio in Q2 2026, its #661 holding.
Boothbay Fund Management first reported a position in Elevance Health in Q4 2015 and has held it in 15 quarters since.
Boothbay Fund Management's Elevance Health position peaked at $5.33M in Q4 2022.
1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.